Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer
This study is ongoing, but not recruiting participants.
Study NCT00652691
Information provided by Mayo Clinic
First Received on April 3, 2008.
Last Updated on June 25, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
